Cargando…
FRI147 A Direct-To-Patient Primary Aldosteronism Screening Program In The United States: Implementing Guidelines Nationwide
Disclosure: J.M. Brown: Consulting Fee; Self; Bayer, Inc. B. Bacare: None. Y.M. Niebuhr: None. L.C. Tsai: None. E.E. Abel: None. B. Honzel: None. A. Vaidya: Consulting Fee; Self; Corcept Therapeutics, HRA Pharmaceuticals, Mineralys. Context: Primary aldosteronism (PA) is a prevalent but grossly unde...
Autores principales: | Michelle Brown, Jenifer, Bacare, Bassil, Niebuhr, Yvonne M, Tsai, Laura C, Abel, Eva E, Honzel, Brooke, Vaidya, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554426/ http://dx.doi.org/10.1210/jendso/bvad114.659 |
Ejemplares similares
-
FRI154 Saline Suppression Testing And Acute Hypocalcemia: Impacts On Diagnostic Testing For Primary Aldosteronism
por: Warachit Parksook, Wasita, et al.
Publicado: (2023) -
FRI142 The Pathophysiologic Spectrum Of Primary Aldosteronism Determined Via Saline Suppression Testing In Overweight Hypertensive And Pre-hypertensive People
por: Warachit Parksook, Wasita, et al.
Publicado: (2023) -
OR20-3 Characterization of the Pathophysiologic Spectrum of Subclinical Primary Aldosteronism in Normotension
por: Auchus, Richard J, et al.
Publicado: (2022) -
PSUN51 Re-Calibrating Aldosterone Assay Interpretations: Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry Measurements Across Multiple Controlled Physiologic Conditions
por: Brown, Jenifer M, et al.
Publicado: (2022) -
FRI122 Determinants Of Primary Aldosteronism Screening In The US: A Nationwide Physician Survey Study
por: Turcu, Adina F, et al.
Publicado: (2023)